Member Info for Oxmil

I’ve been watching it hover around 30% for ages, increasing to over 40% is unusual

Sounded pretty upbeat all round. Lots of emphasis on explaining why the revenue was a bit down on last year and why it will get better, so they know what’s needed.

If that spread is real the market makers look to be trying to discourage new buyers. Wonder if any news prior to AGM

Talking about DoseMe at the moment

HSBC but why would I make that up? I can’t be the only one to receive a letter

My shares are in a nominee account with my bank and the bank have already sent me a letter mentioning the 2 for 10 with a comment of more details to follow. Just no indication of when or what price

Isn’t maternity pay reclaimable from hmrc? So every tax payer rather than just val shareholders paying really

Or she’s just on holiday!

They name a protein they plan to inhibit, I’ve never seen val mention that protein, or ever mention that they are targeting mechanisms of resistance. The only thing in common that I can see is that it will treat cancer

Freddie I don’t think anyone commented because it’s utterly irrelevant. Someone unrelated to us has found a mechanism to treat cancer. We don’t develop drugs for that mechanism so why would we get any money for it?

Was there an RNS with the 6 companies comment though ValJu? I thought it was just a comment GM had made

Adam, she also posted that she would delete any LinkedIn questions and comments that did not relate to her post. It’s her LinkedIn page, I guess she can choose what’s kept on there

You need to go back to listen to Suzy’s interview before Christmas. That gives a better definition of who wrote it and what the peer review does

Didn’t we already get that in the December RNS that told us this was coming out?

Adam, I think it’s a technical article written for scientific reasons, not a PR stunt written for us lot.

I can see the response to Adam and it still doesn’t say anything about a ph3, just next steps

Very fat fingers, it does seem we’ve been waiting a while though

That presentation is from 2016!! Old news, still waiting for November 3018

I thought the point of investing through AIM (rather than peer to peer or crowdfunding for example) is that it’s a regulated market and the AIM regulators check everything in the RNS? So presumably if the RNS says something, it’s true and has been proven to the people we’ve trusted to regulate it (otherwise you wouldn’t invest through AIM in the first place).

Basic research from the website says it’s a drug, not a biologic and not immunotherapy